Acantholysis
| Acantholysis | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Blistering, erosions, ulcers |
| Complications | Infection, scarring |
| Onset | Varies depending on underlying cause |
| Duration | Chronic or acute |
| Types | N/A |
| Causes | Autoimmune disease, genetic disorder, infection |
| Risks | |
| Diagnosis | Skin biopsy, immunofluorescence |
| Differential diagnosis | Pemphigus, bullous pemphigoid, dermatitis herpetiformis |
| Prevention | Depends on underlying cause |
| Treatment | Corticosteroids, immunosuppressants, antibiotics |
| Medication | |
| Prognosis | Varies; can be managed with treatment |
| Frequency | Rare |
| Deaths | N/A |
Acantholysis is a pathological condition characterized by the loss of cohesion between keratinocytes, the predominant cell type in the epidermis. This process leads to the breakdown of the epidermal structure, resulting in the formation of blisters and erosions on the skin and mucous membranes.
Pathophysiology[edit]
Acantholysis occurs due to the disruption of desmosomes, which are specialized structures that facilitate cell-to-cell adhesion in the epidermis. The loss of desmosomal function can be caused by various factors, including autoimmune diseases, genetic mutations, and infections. The detachment of keratinocytes leads to the formation of intraepidermal clefts and vesicles.
Causes[edit]
Acantholysis can be seen in several dermatological conditions, including:
- Pemphigus vulgaris: An autoimmune disease where autoantibodies target desmogleins, components of desmosomes.
- Pemphigus foliaceus: Another autoimmune condition affecting desmogleins, but typically less severe than pemphigus vulgaris.
- Hailey-Hailey disease: A genetic disorder caused by mutations in the ATP2C1 gene, leading to defective calcium transport and impaired desmosomal function.
- Darier's disease: A genetic condition resulting from mutations in the ATP2A2 gene, affecting calcium homeostasis and desmosomal integrity.
- Herpes simplex virus infection: The virus can cause acantholysis by directly infecting keratinocytes and disrupting their adhesion.
Clinical Presentation[edit]
Patients with acantholysis may present with:
- Blisters: Fluid-filled lesions that can rupture, leading to erosions.
- Erosions: Areas where the epidermis has been lost, exposing the underlying dermis.
- Crusting: Formation of dried exudate on the skin surface.
- Pruritus: Itching, which may accompany the lesions.
Diagnosis[edit]
The diagnosis of acantholysis is typically made through:
- Clinical examination: Observation of characteristic skin lesions.
- Skin biopsy: Histopathological examination revealing loss of keratinocyte cohesion and intraepidermal clefting.
- Direct immunofluorescence: Detection of autoantibodies in autoimmune conditions like pemphigus vulgaris.
Treatment[edit]
The treatment of acantholysis depends on the underlying cause:
- Corticosteroids: Used to reduce inflammation and immune response in autoimmune conditions.
- Immunosuppressive agents: Such as azathioprine or mycophenolate mofetil for severe autoimmune cases.
- Antiviral medications: For acantholysis caused by herpes simplex virus infection.
- Topical treatments: Including antibiotics and emollients to manage secondary infections and maintain skin hydration.
Prognosis[edit]
The prognosis of acantholysis varies depending on the underlying condition and the effectiveness of treatment. Autoimmune conditions like pemphigus vulgaris can be chronic and require long-term management, while infections may resolve with appropriate antiviral therapy.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian